Vaccines in the Era of Emerging Infectious Diseases: Immune Mechanisms and Innovations

Emerging infectious diseases (EIDs) continue to challenge global public health, driven by factors like climate change, urbanization, and increasing human-animal interactions. The rapid spread of the COVID-19 pandemic highlighted the need for swift vaccine development and deployment. Vaccines remain one of the most effective public health tools, capable of preventing disease outbreaks by inducing immunity through humoral and cell-mediated mechanisms. Recent advancements in immunology and biotechnology have revolutionized vaccine development, enabling the creation of new platforms such as mRNA vaccines, viral vectors, and nanoparticle-based vaccines. These innovations allow for faster production, greater efficacy, and adaptability to novel pathogens. Additionally, new delivery methods, including microneedle patches and nasal sprays, aim to improve accessibility and ease of administration, particularly in low-resource settings. However, challenges such as vaccine equity, distribution logistics, and public hesitancy must be addressed to ensure broad and effective vaccination coverage. This review explores the immune mechanisms of vaccines, current vaccine technologies, and emerging innovations to address EIDs, with a focus on future preparedness for pandemics. Keywords: Emerging infectious diseases, vaccines, mRNA technology, nanoparticle vaccines, immune mechanisms, vaccine innovations